|
Volumn 23, Issue 22, 2013, Pages 6064-6067
|
Hit-to-lead optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as a novel class of EP1 receptor antagonists
|
Author keywords
EP1 receptor antagonist; HTS; Overactive bladder; Pyrazole; Thiazole
|
Indexed keywords
2 (1H PYRAZOL 1 YL)THIAZOLE DERIVATIVE;
PROSTAGLANDIN RECEPTOR BLOCKING AGENT;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG SCREENING;
DRUG SYNTHESIS;
HUMAN;
MALE;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
EP(1) RECEPTOR ANTAGONIST;
HTS;
OVERACTIVE BLADDER;
PYRAZOLE;
THIAZOLE;
ANIMALS;
HUMANS;
MICE;
MODELS, MOLECULAR;
PYRAZOLES;
RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIAZOLES;
|
EID: 84885951591
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2013.09.032 Document Type: Article |
Times cited : (14)
|
References (13)
|